Quick Answer
Paperless QMS software replaces paper quality records and manual routing with electronic workflows for documents, training, deviations, CAPA, change control, audits, and other QMS processes. In FDA-regulated environments, going paperless requires more than scanning documents. The company must preserve controlled records, validate intended use, manage access, maintain audit trails, control electronic signatures, and retrieve complete records during inspections.
Key Takeaways
- Paperless QMS is not just PDF storage. It is controlled electronic quality record management.
- Part 11 may apply when electronic records or signatures replace paper regulated records.
- Audit trails, access control, retention, and electronic signatures should be designed before migration.
- Paperless systems should reduce inspection retrieval time and version ambiguity.
- The highest-value paperless QMS workflows are document control, training, deviations, CAPA, and change control.
- Paperless QMS software can reduce manual work, but only when the system preserves record integrity. If a paper process is poorly controlled, digitizing it can make problems faster and harder to unwind.
- This guide explains how to move paper QMS workflows into electronic control.
- Going paperless is a quality-system change, not an IT cleanup project. The company has to decide which electronic records become authoritative, which signatures replace handwritten approvals, which audit trails are required, which legacy records remain paper, and how users will be trained before the new process becomes effective.
- The safest paperless programs start with the record lifecycle. For each workflow, define how the record is created, reviewed, approved, revised, retained, retrieved, archived, and retired. Then configure software to enforce that lifecycle.
What Paperless QMS Should Replace
| Paper Process | Paperless Equivalent |
|---|---|
| Wet-signature SOP approvals | Electronic review and signature workflow |
| Training binders | Training assignments and completion records |
| Deviation forms | Electronic investigation workflow |
| CAPA logs | Controlled CAPA records with due dates and effectiveness checks |
| Change forms | Electronic change control and impact assessment |
| Audit binders | Audit plans, findings, responses, and evidence |
| File-room retrieval | Searchable controlled record repository |
The system should preserve meaning, approval, history, and retrieval, not only image files.
What Should Become Authoritative Electronically
Before migration, decide which records will be official in the paperless system. This is more important than the scanning plan.
Examples include:
- Current SOPs, policies, templates, specifications, and forms
- Training records tied to effective procedures
- Deviation, nonconformance, CAPA, complaint, and change records
- Audit plans, findings, responses, and follow-up evidence
- Supplier qualification, quality agreement, and SCAR records
- Validation protocols, reports, and approval records
- Management review inputs and outputs
Some legacy records may remain paper or archived PDFs. That can be acceptable if procedures define which record is authoritative, how it is retrieved, and how long it is retained. The risk is a hybrid system where users do not know whether the official record is the binder, the scan, the email approval, or the QMS workflow.
Paperless Does Not Mean Recordless
A paperless QMS still needs complete records. The difference is that the record is created and controlled electronically. That means the system must preserve:
- Who performed the action
- What record was created or changed
- When the action occurred
- Which version was effective
- Which approvals or signatures were applied
- Which attachments or evidence were part of the record
- Whether the record was superseded, withdrawn, voided, or archived
If the electronic system cannot answer those questions, the company may have less control than it had with paper.
Part 11 Considerations
FDA's Part 11 framework becomes relevant when regulated records or signatures are maintained electronically. For paperless QMS, evaluate:
- Which records are predicate-rule records
- Whether electronic record is the authoritative record
- Audit trail coverage
- Electronic signature controls
- User access and authority checks
- Record retention and retrieval
- System validation
- Backup and archive strategy
Hybrid paper-electronic systems can create ambiguity. Define which record is authoritative for each process.
Part 11 should be assessed record by record and signature by signature. Not every electronic file in a company is automatically a Part 11 record, but when an electronic record is used to meet an FDA predicate rule requirement or an electronic signature replaces a handwritten signature, the controls matter.
The company's assessment should identify:
- Predicate-rule records affected by the paperless workflow
- Whether the electronic record is the official record
- Whether electronic signatures are legally binding in the workflow
- Required audit trail coverage
- Retention period and archive method
- Ability to generate accurate and complete copies
- Validation approach for intended use
- Procedures for access, authority checks, password controls, and training
Electronic Signature Design
Electronic signatures should match the approval being made. A training acknowledgment, SOP approval, CAPA closure, deviation approval, and change-control approval may carry different meaning and risk.
When designing signatures, define:
- What the signer is certifying
- Whether the signature is review, approval, authorship, verification, or closure
- Whether signature meaning appears on the record
- Whether the signer must re-enter credentials
- Whether delegated signing is allowed
- Whether signatures remain linked to the record after export or archive
- Whether signature events appear in the audit trail
This prevents electronic signatures from becoming generic clicks that do not explain what was approved.
Validation and Computer Software Assurance
Paperless QMS software usually needs validation or assurance based on intended use and risk. For medical-device production and quality management system software, FDA's 2026 computer software assurance guidance describes a risk-based approach for establishing confidence in automation used for production or quality management activities.
The practical validation question is not "is the vendor validated?" The regulated company should define how it intends to use the system, which records and workflows are in scope, what configuration is critical, what risks exist if the system fails, and what testing or assurance evidence is appropriate.
Validation evidence may include requirements, configuration review, risk assessment, vendor assessment, test scripts, unscripted testing, data migration checks, user acceptance testing, traceability, approvals, and release/change control.
Migration Risks
| Risk | Control |
|---|---|
| Scanned documents lack metadata | Define document taxonomy and required fields |
| Old versions remain active | Control obsolete documents before migration |
| Missing approval history | Preserve or document legacy approval evidence |
| Users bypass workflows | Train and retire uncontrolled processes |
| Poor search terms | Standardize naming and metadata |
| No validation plan | Validate intended use before go-live |
Paperless success depends on migration discipline.
Recommended Migration Sequence
Most teams should not digitize every workflow at once. A practical sequence is:
- Document control
- Training
- Deviations and nonconformances
- CAPA
- Change control
- Audit management
- Supplier quality
- Management review and metrics
Document control and training usually come first because they define how procedures become effective and how users become qualified to follow them. CAPA and change control usually follow because they depend on controlled procedures, records, training, and approvals.
Data Migration Checks
Data migration is often underestimated. Before go-live, teams should verify:
- Legacy documents have correct title, number, version, status, owner, and effective date.
- Obsolete documents are clearly separated from current documents.
- Required approval history is preserved or documented.
- Training assignments map to the correct procedure version.
- Open deviations, CAPA, audits, and changes retain ownership and due dates.
- Attachments are complete and readable.
- Search metadata works for inspection retrieval.
For high-risk records, sample-based checks may not be enough. Teams should define migration acceptance criteria before moving data.
Hybrid Period Controls
Most companies have a transition period where some workflows are paper, some are electronic, and some records are being migrated. That period needs explicit control.
Define:
- Date when each workflow becomes electronic
- Whether paper forms are retired or still allowed
- How in-progress records are completed
- How paper approvals are handled after go-live
- Who can create new records outside the system
- How legacy records are retrieved during inspection
- How users know which process is current
The highest risk in a paperless project is often not the new system. It is the overlap between old and new processes.
Inspection Readiness Benefits
Paperless QMS is worth the effort when it improves inspection readiness. A team should be able to retrieve:
- Current effective SOPs and prior versions
- Training records for a person, role, procedure, or date
- Deviation investigations and related CAPA
- Change control history and regulatory impact assessment
- Audit findings and responses
- Supplier qualification and follow-up records
- Electronic signatures and audit trails
This retrieval should happen without relying on local drives, screenshots, email chains, or manual binders created after the fact.
How Assyro Fits
Assyro helps teams test whether paperless QMS records are actually usable during inspection and submission work. QMS document control software, audit trail requirements, and Regulatory Gap Analysis help surface missing metadata, weak version control, incomplete audit trails, and evidence gaps before they become inspection or filing problems.
A paperless record is most useful when it can be linked to product context, regulatory impact assessment, submission sections, health authority responses, and inspection requests.
Paperless QMS software manages quality documents and records electronically instead of relying on paper forms, binders, wet signatures, and manual logs.
References
This guide reflects FDA Part 11 and regulated-record information current as of May 2026. Confirm intended use, predicate rules, and retention requirements before going paperless.
About the author
Assyro Team
Expert regulatory operations consultants helping pharmaceutical companies navigate complex compliance challenges.
See Assyro in action
Catch eCTD and eSTAR errors before your FDA review cycle.
Book a 20-minute demo this week. We'll validate a sample of your submission live and show you exactly where Assyro catches what your current QC misses.